EuroBloodNet Association

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Luspatercept in Patients Affected With Rare Inherited Anemias	Hereditary Red Blood Cell Disorder (Disorder)	Not yet recruiting	Phase 2	2026-01-12	NCT07331818
RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Hemolysis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alpha thalassemia spectrum, anemia, beta thalassemia, bone marrow disorder, congenital dyserythropoietic anemia, cystinosis, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary anemia, hereditary disease, inborn errors of metabolism, inherited aplastic anemia, inherited hemoglobinopathy, iron metabolism disease, lysosomal storage disease, metabolic disease, myelodysplastic syndrome, pyruvate kinase deficiency of red cells, sickle cell disease, sideroblastic anemia, thalassemia	Recruiting	Not stated	2024-01-19	NCT06213402
Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies	Hereditary Red Blood Cell Disorder (Disorder)	Not yet recruiting	Phase 2	2023-12-26	NCT05935202

Clinical trials